Follow
Lorenzo Maso
Lorenzo Maso
NYU Perlmutter Cancer Center
Verified email at nyulangone.org
Title
Cited by
Cited by
Year
A chloroplast-localized mitochondrial calcium uniporter transduces osmotic stress in Arabidopsis
E Teardo, L Carraretto, R Moscatiello, E Cortese, M Vicario, M Festa, ...
Nature plants 5 (6), 581-588, 2019
612019
ER-mitochondria calcium transfer, organelle contacts and neurodegenerative diseases
F Vallese, L Barazzuol, L Maso, M Brini, T Calì
Calcium Signaling, 719-746, 2020
372020
Unveiling the binding mode of perfluorooctanoic acid to human serum albumin
L Maso, M Trande, S Liberi, G Moro, E Daems, S Linciano, F Sobott, ...
Protein Science 30 (4), 830-841, 2021
302021
X-ray crystallography deciphers the activity of broad-spectrum boronic acid β-lactamase inhibitors
L Cendron, A Quotadamo, L Maso, P Bellio, M Montanari, G Celenza, ...
ACS Medicinal Chemistry Letters 10 (4), 650-655, 2019
282019
Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases
F Spyrakis, M Santucci, L Maso, S Cross, E Gianquinto, F Sannio, ...
Scientific Reports 10 (1), 12763, 2020
262020
A-to-I editing of Malacoherpesviridae RNAs supports the antiviral role of ADAR1 in mollusks
U Rosani, CM Bai, L Maso, M Shapiro, M Abbadi, S Domeneghetti, ...
BMC evolutionary biology 19, 1-18, 2019
242019
Creating MHC-restricted neoantigens with covalent inhibitors that can be targeted by immune therapy
T Hattori, L Maso, KY Araki, A Koide, J Hayman, P Akkapeddi, I Bang, ...
Cancer discovery 13 (1), 132-145, 2023
212023
Exploring iron-binding to human frataxin and to selected Friedreich ataxia mutants by means of NMR and EPR spectroscopies
M Bellanda, L Maso, D Doni, M Bortolus, E De Rosa, F Lunardi, A Alfonsi, ...
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1867 (11), 140254, 2019
202019
Identifying conformational changes with site-directed spin labeling reveals that the GTPase domain of HydF is a molecular switch
L Galazzo, L Maso, E De Rosa, M Bortolus, D Doni, L Acquasaliente, ...
Scientific reports 7 (1), 1714, 2017
182017
4-Amino-1,2,4-triazole-3-thione as a Promising Scaffold for the Inhibition of Serine and Metallo-β-Lactamases
P Linciano, E Gianquinto, M Montanari, L Maso, P Bellio, ...
Pharmaceuticals 13 (3), 52, 2020
152020
Characterization of the [FeFe]-hydrogenase maturation protein HydF by EPR techniques: insights into the catalytic mechanism
M Albertini, L Galazzo, L Maso, F Vallese, P Berto, E De Rosa, ...
Topics in Catalysis 58, 708-718, 2015
152015
Biophysical characterisation of the recombinant human frataxin precursor
IH Castro, A Ferrari, MG Herrera, ME Noguera, L Maso, M Benini, A Rufini, ...
FEBS open bio 8 (3), 390-405, 2018
82018
Nanobodies targeting LexA autocleavage disclose a novel suppression strategy of SOS-response pathway
L Maso, F Vascon, M Chinellato, F Goormaghtigh, P Bellio, ...
Structure 30 (11), 1479-1493. e9, 2022
72022
An evolutionary perspective of dopachrome tautomerase enzymes in metazoans
U Rosani, S Domeneghetti, L Maso, KM Wegner, P Venier
Genes 10 (7), 495, 2019
72019
A conformational study of the GTPase domain of [FeFe]-hydrogenase maturation protein HydF by PELDOR spectroscopy
L Maso, L Galazzo, F Vallese, M Di Valentin, M Albertini, E De Rosa, ...
Applied Magnetic Resonance 46, 465-479, 2015
62015
Exploring switch II pocket conformation of KRAS (G12D) with mutant-selective monobody inhibitors
P Akkapeddi, T Hattori, I Khan, E Glasser, A Koide, G Ketavarapu, ...
Proceedings of the National Academy of Sciences 120 (28), e2302485120, 2023
22023
Targeting the class a carbapenemase GES-5 via virtual screening
R Klein, L Cendron, M Montanari, P Bellio, G Celenza, L Maso, D Tondi, ...
Biomolecules 10 (2), 304, 2020
22020
Snapshots of Pseudomonas aeruginosa SOS response activation complex reveal structural prerequisites for LexA engagement and cleavage
F Vascon, S De Felice, M Gasparotto, S Huber, C Catalano, M Chinellato, ...
bioRxiv, 2024.03. 22.585941, 2024
2024
Abstract B020: Creating actionable neoantigens by design with KRAS (G12C) covalent inhibitors
L Maso, T Hattori, K Araki, A Koide, E Rajak, J Hayman, P Akkapeddi, ...
Molecular Cancer Research 21 (5_Supplement), B020-B020, 2023
2023
Abstract B013: Exploring the switch II pocket of KRAS (G12D) with mutant-selective monobody inhibitors
T Hattori, P Akkapeddi, I Khan, A Koide, E Glasser, G Ketavarapu, ...
Molecular Cancer Research 21 (5_Supplement), B013-B013, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20